"Il Centro Clinico NeMO Milano (NEuroMuscular Omnicentre) è un Centro Clinico ad alta specializzazione, pensato per rispondere in modo specifico alle necessità di chi è affetto da malattie neuromuscolari come la SLA , la SMA e le distrofie muscolari. Lo scopo è migliorare la qualità di vita delle persone prese in carico, fornendo loro e alle famiglie un supporto clinico, assistenziale e psicologico che risponda ai bisogni globali. Realtà viva e vitale sul territorio, negli anni il NeMO ha dimostrato di essere un progetto replicabile. Un modello di sanità unico dove tutto ruota attorno al malato e alla sua famiglia."

During the past decade, Centro Clinico NEMO conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Clinico NEMO" #1 sponsor was "Amylyx Pharmaceuticals Inc." with 2 trials, followed by "Cooperative International Neuromuscular Research Group" with 2 trials sponsored, "Italfarmaco" with 2 trials sponsored, "Ferrer Internacional S.A." with 1 trials sponsored and "FibroGen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Clinico NEMO" #1 collaborator was "Fondazione Serena Onlus - Centro Clinico NeMO Milano" with 2 trials as a collaborator, "Carolinas Medical Center" with 1 trials as a collaborator, "Children's National Research Institute" with 1 trials as a collaborator, "Cromsource" with 1 trials as a collaborator and "Julius Clinical" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centro Clinico NEMO" are "Duchenne Muscular Dystrophy" (4 trials), "Amyotrophic Lateral Sclerosis" (3 trials), "ALS" (1 trials), "Becker Muscular Dystrophy" (1 trials) and "Congenital Myotonic Dystrophy" (1 trials). Many other conditions were trialed in "Centro Clinico NEMO" in a lesser frequency.

Most popular intervention types in "Centro Clinico NEMO" are "Drug" (7 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMX0035" (2 trials), "placebo" (2 trials), "Corticosteroids" (1 trials) and "FAB122" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Clinico NEMO" are 5 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Clinico NEMO". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 3 completed trials in Centro Clinico NEMO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Clinico NEMO, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".